L-738372 is a non-competitive, reversible inhibitor of HIV-1 reverse transcriptase (RT) with potential applications in anti-HIV research; it exhibits synergistic inhibition of RT activity when combined with nucleoside analogs (e.g., zidovudine triphosphate, didanosine triphosphate, or deoxycytidine triphosphate); it shows 2- to 3-fold greater inhibitory potency against AZT-resistant RT (D67N, K70R, T215Y, K219Q) compared to wild-type RT.